LYA-Onco 1 Drug Detail
Label-linked therapy, administration, access, and operational details for provider teams.
NDC: 00000-101-01
Route: Infusion
HCPCS: C9399 (temporary, payer-specific mapping)
REMS: No
Clinical Profile
Core facts providers need during therapy onboarding and maintenance.
Provider Tools
Common resources used by office and infusion teams.
Monitoring and Administration Workflow
Operational checkpoints used across provider, nursing, and reimbursement staff.
Contraindications
- History of life-threatening hypersensitivity to active ingredient
- Uncontrolled active infection prior to first dose
- Do not restart after grade 4 infusion reaction
Administration Notes
- Loading dose day 1, then maintenance every 21 days
- Premedication protocol recommended for first 2 infusions
- Observe for 30 minutes after completion for first cycle
Monitoring Matrix
Baseline
Required: CBC, CMP, hepatic panel
Owner: Ordering provider
Each cycle
Required: LFT review and toxicity grading
Owner: Infusion nurse + provider
Dose hold
Required: Document trigger and restart criteria
Owner: Provider + authorization team
Distribution and Access
Supply, coding, and payer preparation details.
Specialty distributor
Lya Direct Distribution Network
Typical ship SLA
Next business day after clean order
Cold chain monitor
Included in every shipment
Payer Readiness
Evidence package components frequently requested for initial authorization.
On-label diagnosis with staging
Recommended evidence: Pathology report + staging note
Prior treatment history
Recommended evidence: Medication administration record
Performance status requirement
Recommended evidence: Recent clinical assessment
Interaction Watchouts
- Avoid concurrent strong immunosuppressants outside label guidance
- Coordinate vaccine timing around treatment cycles
- Review hepatic-metabolism agents in polypharmacy profiles
Capture Local Notes
Add site-specific details that are not in national references.
Add Drug Detail Note
Capture local administration, coverage, or logistics notes.
Add Access Escalation
Log payer obstacle details and escalation owner for this therapy.